Search Results - "Fugere, Brad"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Weight loss (WL) as a predictive factor for immune oncology (IO)

    Weight loss (WL) as a predictive factor for immune oncology (IO) by Fugere, Brad, Chen, Jim Zhongning, Mazahreh, Farah, Fugere, Tyler, Mazahreh, Liyan, Safar, A. Mazin

    Published in Journal of clinical oncology (01-06-2023)
    “…e14528 Background: WL is an adverse prognostic factor/symptom reported in ~40% cancer (ca) patients (pts) at diagnosis agnostic to site or histologic grade…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Interdigitating Dendritic Cell Sarcoma and Indeterminate Dendritic Cell Tumor: Patient Characteristics, Prognostic Factors, and Survival Outcomes for Rare Dendritic Cell Neoplasms

    Interdigitating Dendritic Cell Sarcoma and Indeterminate Dendritic Cell Tumor: Patient Characteristics, Prognostic Factors, and Survival Outcomes for Rare Dendritic Cell Neoplasms by Fugere, Tyler, Fugere, Brad, Amisha, Fnu, Chen, Jim Zhongning, Mukherjee, Akash, Gaddam, Mamatha, Veeraputhiran, Muthu, Gentille Sanchez, Cesar Giancarlo

    Published in Blood (02-11-2023)
    “…Background Dendritic cells are nonlymphoid, nonphagocytic, antigen-presenting cells present in lymphoid and nonlymphoid tissue. There are 4 types of dendritic…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Abstract 4385: Unprecedented tumor: immune interaction–clinical and drug-development implications

    Abstract 4385: Unprecedented tumor: immune interaction–clinical and drug-development implications by Mazahreh, Farah, Mazahreh, Liyan, Fugere, Brad, Safar, Ahmad Mazin

    Published in Cancer research (Chicago, Ill.) (04-04-2023)
    “…Abstract Background: Classic therapeutic (RX) oncology principles demand radiographic response or durable stable disease as surrogates of overall survival (OS)…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: